Suppr超能文献

131I-6β-碘甲基去甲胆固醇闪烁扫描术:评估其在肾上腺皮质意外瘤检查中的作用

131I-6 beta-iodomethylnorcholesterol scintigraphy: an assessment of its role in the investigation of adrenocortical incidentalomas.

作者信息

Bardet S, Rohmer V, Murat A, Guillemot C, Maréchaud R, Chupin M, Lecomte P, Simon D, Delemer B, Schneebelli S, Beutter D, Jacquin V, Peltier P, Charbonnel B

机构信息

Service de Médecine Nucléaire, Centre François Baclesse, Caen, France.

出版信息

Clin Endocrinol (Oxf). 1996 May;44(5):587-96. doi: 10.1046/j.1365-2265.1996.720541.x.

Abstract

OBJECTIVE

Most incidentally discovered adrenal tumours ('incidentaloma') are benign adrenocortical adenomas. It has been suggested that 131I-6 beta-iodomethylnorcholesterol (IMC) scan could specify the degree of functional autonomy of such adenomas depending on whether they prevent contralateral adrenal tracer uptake. Our purpose was to examine this hypothesis in a correlated scintigraphic and endocrine study.

DESIGN

Prospective study evaluating the prevalence of unilateral IMC uptake (tumour uptake with no visualization of the contralateral adrenal gland) and bilateral uptake (uptake in both the tumoral and the contralateral adrenal glands) in patients with unilateral incidentaloma. Comparison of adrenocortical function and of IMC scan after dexamethasone (DXM) in the two scintigraphic groups thus defined.

PATIENTS

Thirty-five patients with a unilateral mass highly suggestive of benign adrenocortical adenoma on CT scan.

MEASUREMENTS

The IMC scan was performed in basal conditions (baseline scan) and after DXM (suppression scan). Adrenocortical function assessment included basal measurements of 11-deoxycortisol, 17 alpha-hydroxyprogesterone (17-OHP), dehydroepiandrosterone sulphate (DHEAS), plasma cortisol and ACTH, urinary free cortisol (UFC), overnight and low-dose DXM suppression test, and CRH test.

RESULTS

The baseline scan showed 16 patients (46%) with unilateral uptake (group A) and 19 (54%) with bilateral uptake (group B). Patients in group A exhibited lower ACTH values at 0800h (P = 0.05) and higher cortisol values after an overnight DXM suppression test (P = 0.02), than did patients in group B. In addition, 3 patients in group A failed the overnight and the low-dose DXM suppression tests. Adrenal masses were larger in group A than group B (P = 0.04) and an inverse correlation was found in the whole population between tumour size and ACTH value at 0800h (P = 0.05). On the suppression scan performed in 14 patients (7 in each group), patients in group A continued to exhibit unilateral tumour uptake and bilateral uptake was suppressed in 72% of patients in group B. An adrenal mass was removed in 3 patients of group A with confirmed benign adrenocortical adenomas. In the post-surgical period, the contralateral gland was again visualized in a baseline scan and the hormonal evaluation returned to the normal range.

CONCLUSION

Unilateral 131I-6 beta-iodomethylnorcholesterol tumour uptake is a frequent feature in benign adrenocortical adenomas. Hormonal data and scintigraphic profiles obtained after dexamethasone, as well as hormonoscintigraphic changes observed after surgery, provide evidence that unilateral uptake is related to functioning adenomas with various degrees of autononomy and suggest that the 131I-6 beta-iodomethylnorcholesterol scan could be a valuable tool for screening 'subclinical' Cushing's adenomas.

摘要

目的

大多数偶然发现的肾上腺肿瘤(“偶发瘤”)是良性肾上腺皮质腺瘤。有人提出,131I - 6β - 碘甲基去甲胆固醇(IMC)扫描可根据腺瘤是否阻止对侧肾上腺摄取示踪剂来确定此类腺瘤的功能自主性程度。我们的目的是在一项相关的闪烁扫描和内分泌研究中检验这一假设。

设计

前瞻性研究,评估单侧偶发瘤患者单侧IMC摄取(肿瘤摄取而对侧肾上腺无显影)和双侧摄取(肿瘤及对侧肾上腺均有摄取)的发生率。对如此定义的两个闪烁扫描组患者的肾上腺皮质功能及地塞米松(DXM)后IMC扫描结果进行比较。

患者

35例患者,CT扫描显示单侧肿块高度提示为良性肾上腺皮质腺瘤。

测量

在基础状态(基线扫描)和DXM后(抑制扫描)进行IMC扫描。肾上腺皮质功能评估包括基础状态下11 - 脱氧皮质醇、17α - 羟孕酮(17 - OHP)、硫酸脱氢表雄酮(DHEAS)、血浆皮质醇和促肾上腺皮质激素(ACTH)、尿游离皮质醇(UFC)、过夜及小剂量DXM抑制试验以及促肾上腺皮质激素释放激素(CRH)试验。

结果

基线扫描显示16例患者(46%)为单侧摄取(A组),19例(54%)为双侧摄取(B组)。A组患者在08:00时的ACTH值较低(P = 0.05),过夜DXM抑制试验后的皮质醇值较高(P = 0.02),均高于B组患者。此外,A组有3例患者过夜及小剂量DXM抑制试验未通过。A组肾上腺肿块大于B组(P = 0.04),且在整个人群中发现肿瘤大小与08:00时的ACTH值呈负相关(P = 0.05)。在14例患者(每组7例)进行的抑制扫描中,A组患者继续表现为单侧肿瘤摄取,B组72%的患者双侧摄取被抑制。A组3例确诊为良性肾上腺皮质腺瘤的患者接受了肾上腺肿块切除。术后,基线扫描中对侧肾上腺再次显影,激素评估恢复至正常范围。

结论

单侧131I - 6β - 碘甲基去甲胆固醇肿瘤摄取是良性肾上腺皮质腺瘤的常见特征。地塞米松后获得的激素数据和闪烁扫描特征,以及手术后观察到的激素闪烁扫描变化,均表明单侧摄取与具有不同自主程度的功能性腺瘤有关,并提示131I - 6β - 碘甲基去甲胆固醇扫描可能是筛查“亚临床”库欣腺瘤的有价值工具。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验